Search Results
#
Altay Therapeutics Receives Orphan Drug Designationfor DX5057
Dec 3, 2025, 12:53 PM
Early investment by Friends pays off.
#
Update: Determining in vitro and in vivo efficacy of novel DUX4 inhibitors
Apr 6, 2023, 12:24 PM
Final update by Dr. Ozes of Altay Therapeutics.
#
Update: Determining in vitro and in vivo efficacy of novel DUX4 inhibitors
Aug 4, 2022, 12:47 PM
Dr. Ozes provides a brief update on progress in testing quite novel DUX4 inhibitors.
#
Progress Update: The discovery of a novel small molecule inhibitor for DUX4
Sep 24, 2021, 4:38 PM
Dr. Ozes provides an update to his successful work in finding a potential small molecule inhibitor for DUX4.